Companies / Argentina
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Growing Resentment On Price Controls
November 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Argentine pharmaceutical industry associations CAEME, CILFA and CPERALA have insisted that member companies have not significantly raised prices since the introduction of anti-inflation controls late last year. Firms argue that while the consumer price index was up 6.4% year-on-year in September 2006, pharmaceutical prices increased by an average of just 2.5%. However, a number of recent surveys by consumer groups claim larger rises in some specific therapeutic